ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: L02

Mutational Analysis of UNC93B1 Identifies Regulatory Regions Mutated in Human SLE

John Huizar1, Victoria Rael2, Julian Yano2, Leianna Slayden3, Madeleine Weiss4, Robert Saxton4, Bo Liu5, Olivia Majer6 and Gregory Barton7, 1UCSF, San Francisco, CA, 2Division of Immunology and Molecular Medicine, Department of Molecular and Cell Biology, UC Berkeley, Berkeley, CA, 3HHMI at UC Berkeley, Berkeley, CA, 4UC Berkeley, Berkeley, CA, 5Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shangai, China, 6Max Planck Institute for Infection Biology, Berlin, Germany, 7UC Berkeley / HHMI, Berkeley, CA

Meeting: ACR Convergence 2023

Date of first publication: October 24, 2023

Keywords: genetics, innate immunity, Late-Breaking 2023, Mouse Models, Lupus, signal transduction, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: Late-Breaking Abstract Poster

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Endosomal nucleic acid-sensing toll-like receptors 3, 7 and 9 are key innate immune sensors of dsRNA, ssRNA and ssDNA, respectively, whose activities must be tightly regulated to prevent systemic autoimmune or autoinflammatory disease (TLR7, TLR9) or virus-associated immunopathology (TLR3). The 12-pass transmembrane protein UNC93B1 chaperones nascent TLR3, TLR7 and TLR9 molecules from the ER to endosomes that support ligand recognition and signaling. Release from UNC93B1 is required for TLR3 and TLR9 signaling, whereas a persistent association between UNC93B1 and TLR7 is important for limiting TLR7 responses to endogenous nucleic acids.

Methods: Here we undertook a systematic scanning mutagenesis screen of all cytosolic and endosomal loops of UNC93B1 in murine RAW macrophages, totaling 93 mutated single or triplet amino acid residues.

Results: We identified both negative and positive regulatory regions – in particular, 21, 31 and 17 of these mutations yielded a 2-fold or higher enhancement of TNFa production downstream of TLR3, TLR7 or TLR9, respectively. The number and effect size of negative regulatory UNC93B1 mutations was noted to be highest for TLR7 responses.

We were subsequently contacted by several groups of clinicians who had identified patients with coding mutations in UNC93B1, including: (i) a family of 3 adolescent siblings and with pediatric onset isolated cutaneous tumid lupus, harboring a heterozygous T93I mutation; (ii) an adolescent girl with pediatric onset extended oligoarticular JIA, chillblain and tumid lupus rashes and an ataxic/dystonic movement disorder with CNS basal ganglia calcifications reminiscent of Aicardis-Goutieres syndrome, harboring a heterozygous R336C mutation not present in either of her parents; and (iii) a young man diagnosed at age 10 with SLE complicated by aggressive class IV nephritis, harboring a homozygous G590E mutation. When introduced in to human THP-1 monocytes and murine RAW macrophages, these mutations enhanced cytokine responses to TLR7 (expressed in mouse and human cells), TLR8 (human cells only), and to a lesser extent TLR3 (mouse cells only) stimulation, phenocopying mutants in the same UNC93B1 regions from our original screen. Knock-in mice have been generated for all three human variant alleles, and to date analysis of Unc93b1^(R336C) mice has revealed a 30% reduction in body weight, splenomegaly, expansion of Age-Associated B cells and plasma cells, monocytes and neutrophils, and titers of serum ANA IgG comparable to TLR7.1 transgenic animals.

Conclusion: Altogether our results implicate the UNC93B1-TLR7/8 axis in human monogenic autoimmune disease and provide a functional resource and analysis pipeline to assess the impact of yet-to-be-reported UNC93B1 mutations.


Disclosures: J. Huizar: None; V. Rael: None; J. Yano: None; L. Slayden: None; M. Weiss: None; R. Saxton: None; B. Liu: None; O. Majer: None; G. Barton: None.

To cite this abstract in AMA style:

Huizar J, Rael V, Yano J, Slayden L, Weiss M, Saxton R, Liu B, Majer O, Barton G. Mutational Analysis of UNC93B1 Identifies Regulatory Regions Mutated in Human SLE [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/mutational-analysis-of-unc93b1-identifies-regulatory-regions-mutated-in-human-sle/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/mutational-analysis-of-unc93b1-identifies-regulatory-regions-mutated-in-human-sle/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology